Previous 10 | Next 10 |
Danaher to Present at TD Cowen Health Care Conference PR Newswire WASHINGTON , Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair , will be presenting at the TD Cowen Healthcare ...
2024-02-25 06:27:50 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets PR Newswire WASHINGTON , Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) em...
2024-02-12 06:33:13 ET Summary Akre Capital Management's 13F portfolio value increased by 4% to $11.88B, with 18 positions in total. The largest stakes in the portfolio are Mastercard, Moody's, American Tower, KKR, and O'Reilly Automotive. Akre's cash allocation is currently a...
2024-02-07 05:05:00 ET Summary Historically, InTest derived most of its revenues from the semiconductor capital equipment end market. The company is intentionally growing its business in other end markets to reduce cyclicality and provide a more stable base of cash flows to deploy...
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development PR Newswire Danaher Beacon for Preclinical Drug Safety seeks to address major cause of failure in clinical trials Program will...
2024-02-03 05:17:20 ET Summary Danaher's annual results show a decrease in sales and EBIT due to the boost in sales of the COVID-19 pandemic. The company has made strategic acquisitions and spin-offs to improve its business segments and position itself for long-term growth. Da...
2024-02-01 08:15:02 ET Needham analyst issues OVERWEIGHT recommendation for DHR on February 1, 2024 07:48AM ET. The previous analyst recommendation was Overweight. DHR was trading at $239.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-01-30 13:06:07 ET Summary Despite recent challenges, Danaher remains resilient and strategically positioned for long-term success. Danaher's 4Q23 results, while showing declines, highlight strategic steps and acquisitions, setting the stage for sustained growth. Despite h...
2024-01-30 11:03:03 ET Danaher Corporation (DHR) Q4 2023 Earnings Conference Call January 30, 2024, 08:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Conference Call Participants Dan Br...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...